Mina, an IL-4 Repressor, a Predictor of Atopic Diseases, such as Allergic Rhinitis, Bronchial Asthma and Atopic Dermatitis (SJ-08-0005)
Technology Name (St. Jude Reference #) | Mina, an IL-4 Repressor, a Predictor of Atopic Diseases, such as Allergic Rhinitis, Bronchial Asthma and Atopic Dermatitis (SJ-08-0005) |
| Description | Bronchial asthma and allergic rhinitis are diseases associated with elevated IL-4 production from dysregulated T helper 2 (TH2) cells. Researchers at St. Jude Children's Research Hospital and the RIKEN Yokohama Institute have discovered that Mina regulates the amount of IL-4 produced and that single nucleotide polymorphisms (SNPs) in the Mina locus are associated with asthma and rhinitis. Thus, Mina could be used as a genetic marker to predict susceptibility and diagnosis of allergic diseases and to screen for compounds useful as therapeutic agents. |
| Keywords | Mina, asthma, rhinitis, allergic diseases |
| Granted Patents or Published Applications | International application published on December 17, 2009 as WO 2009/151518 |
| Related Scientific References | Mariko Okamoto, Melanie Van Stry, Linda Chung, Madoka Koyanagi, Xizhang Sun, Yoshie Suzuki, Osamu Ohara, Hiroshi Kitamura, Atsushi Hijikata, Masato Kubo & Mark Bix; Mina, an Il4 repressor, controls T helper type 2 bias; Nature Immunology 10, 872 - 879 (2009) |
| Licensing Opportunities | We are currently seeking licensing opportunities in all fields for the development of this technology. |
| |
Contact the Office of Technology Licensing (Phone: 901-595-2342, Fax: 901-595-3148) for more information.
Last update: September 2010